Navigation Links
Clemson bioengineer wins prestigious Early Career Award
Date:8/15/2008

CLEMSON Ning Zhang, assistant professor of bioengineering at Clemson University and the CU-MUSC Bioengineering Program, has received the prestigious 2008 Early Career Translational Research Award from the Wallace H. Coulter Foundation.

The foundation judged Zhang's research on an injectable hydrogel-based system for the treatment of stroke to be a highly promising technology that can progress towards commercial development and clinical practice. Zhang proposed the injectable hydrogel system to assist stem cell therapy for stroke treatment.

"This award exemplifies the strong leadership of Dr. Zhang in translational biomaterials research based on outstanding basic science," said Martine LaBerge, chair of Clemson's bioengineering department. "Our goal as bioengineers is to get potential life-saving treatments such as this from the research lab to the patient in an expedient manner."

The Early Career Translational Research Awards support biomedical engineering research that is translational in nature and encourage and assist eligible biomedical engineering investigators as they establish themselves in academic research careers with two years of funding.

Zhang's research on neurobioengineering has also been recognized by the 2007 Department of Defense Post-Traumatic Stress Disorder/Traumatic Brain Injury Research Program of the Office of the Congressionally Directed Medical Research Programs (CDMRP) with a Concept Award on "Brain Tissue Regeneration After Traumatic Brain Injury."

The Wallace H. Coulter Foundation is a private, nonprofit foundation in Miami dedicated to improving human healthcare by supporting translational research in biomedical engineering. Recipients of the Early Career Translational Research Awards are full-time, tenure-track faculty members with a primary appointment in biomedical engineering. They have received their doctoral degree no more than six years prior to their application, and they held a rank no higher than assistant professor at the time of application.

Wallace H. Coulter was an engineer, inventor and entrepreneur who applied engineering principles to biomedical problems. He founded Coulter Corp., which developed and marketed the first automated blood cell counters and flow cytometers, instruments that revolutionized healthcare diagnostics and therapeutics. Believing that the contributions of engineers to solving biomedical problems were generally under-recognized, Coulter mentored and encouraged young engineers to dream, take risks and be innovative.


'/>"/>
Contact: Martine LaBerge
laberge@clemson.edu
864-656-5557
Clemson University
Source:Eurekalert

Related biology news :

1. NIH recognizes Clemson nanotechnology for molecule tracking
2. Clemson physicist addresses international forum on thermoelectric energy
3. Clemson scientists shed light on molecules in living cells
4. Clemson chemists discover new way antioxidants fight debilitating diseases
5. UC Riverside bioengineer receives high honor from chemical engineers
6. Brown hosts regional bioengineering conference
7. From stem cells to organs: The bioengineering challenge
8. UCSD bioengineering grad student wins leadership award
9. Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials
10. Bioengineers at University of Pennsylvania devise nanoscale system to measure cellular forces
11. Springer editor Toshisada Nishida winner of 2 prestigious primatology awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... YORK , Jan. 24, 2017 ... study of the laboratory use of nuclear magnetic ... 363 experienced end-users and profiled current practices, developments, ... years, as well as growth and opportunities. These ... Instrument suppliers, NMR instruments, needs and innovation requirements, ...
(Date:1/21/2017)... Jan 20, 2017 Research and Markets has ... 2017-2021" report to their offering. ... The global voice recognition biometrics market to ... The report covers the present scenario and the growth ... calculate the market size, the report considers the revenue generated from ...
(Date:1/18/2017)... Md. , Jan. 18, 2017  In vitro ... respect to mergers and acquisitions (M&A), and Kalorama Information ... for such acquisitions have been shifting. Generally, uncertainty in ... and the U.S. has changed the acquisitions landscape. ... has resulted in companies buying partners outside of their ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
(Date:2/16/2017)... Indiana (PRWEB) , ... February ... ... of Albany Molecular Research Inc. has further extended its industry leading Biochemistry ... This service offers state-of-the-art cGMP techniques and methods for the biochemical ...
(Date:2/15/2017)... ... February 15, 2017 , ... Park Systems , a leader ... AFM operating software that drastically boosts productivity with single click reliable nanoscale images, is ... functions of setting up and taking the image once done manually by the operator ...
(Date:2/15/2017)... Feb. 15, 2017  NASA provider SpaceX is scheduled ... the  International Space Station  no earlier than 10:01 a.m. ... will begin at 8:30 a.m. on NASA Television and ... spacecraft will lift off on the company,s Falcon ... Kennedy Space Center in ...
Breaking Biology Technology: